Literature DB >> 8058949

Stereotaxic 14-gauge breast biopsy: how many core biopsy specimens are needed?

L Liberman1, D D Dershaw, P P Rosen, A F Abramson, B M Deutch, L E Hann.   

Abstract

PURPOSE: To determine the optimum number of specimens to obtain at stereotaxic core breast biopsy.
MATERIALS AND METHODS: Stereotaxic biopsies were performed in 145 mammographically evident lesions by using a dedicated table with patients in the prone position. Samples were obtained with an automated gun and a 14-gauge needle. Indications for biopsy were calcifications (n = 53) and masses (n = 92). Three to 11 (mean, 5.4) core biopsy specimens were obtained per lesion and were analyzed separately.
RESULTS: Diagnostic material was obtained in the first specimen in 102 (70%) of the 145 lesions. Obtaining two, three, four, five, and six core specimens yielded a diagnosis in 117 (81%), 129 (89%), 132 (91%), 137 (94%), and 140 (97%) of the 145 lesions, respectively. Obtaining five specimens yielded a diagnosis in 46 (87%) of the 53 calcifications and 91 (99%) of the 92 masses. Obtaining six specimens resulted in a diagnosis in 49 (92%) lesions evident as calcifications but did not improve the yield on masses.
CONCLUSION: Stereotaxic 14-gauge core biopsy achieved a 99% diagnostic yield with five specimens for masses. Additional specimens may be necessary to diagnose some calcified lesions.

Entities:  

Mesh:

Year:  1994        PMID: 8058949     DOI: 10.1148/radiology.192.3.8058949

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  23 in total

Review 1.  Preoperative assessment of prognostic factors in breast cancer.

Authors:  H Denley; S E Pinder; C W Elston; A H Lee; I O Ellis
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

Review 2.  Stereotactic and ultrasound-guided breast biopsy.

Authors:  T H Helbich; W Matzek; M H Fuchsjäger
Journal:  Eur Radiol       Date:  2003-11-13       Impact factor: 5.315

3.  MRI of the breast in patients with DCIS to exclude the presence of invasive disease.

Authors:  Eline E Deurloo; Jincey D Sriram; Hendrik J Teertstra; Claudette E Loo; Jelle Wesseling; Emiel J Th Rutgers; Kenneth G A Gilhuijs
Journal:  Eur Radiol       Date:  2012-02-26       Impact factor: 5.315

4.  Diagnosing breast cancer by using Raman spectroscopy.

Authors:  Abigail S Haka; Karen E Shafer-Peltier; Maryann Fitzmaurice; Joseph Crowe; Ramachandra R Dasari; Michael S Feld
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

Review 5.  An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens.

Authors:  E A Rakha; I O Ellis
Journal:  J Clin Pathol       Date:  2007-07-14       Impact factor: 3.411

6.  Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice.

Authors:  M F Dillon; C M Quinn; E W McDermott; A O'Doherty; N O'Higgins; A D K Hill
Journal:  J Clin Pathol       Date:  2006-07       Impact factor: 3.411

7.  The accuracy of ultrasound, stereotactic, and clinical core biopsies in the diagnosis of breast cancer, with an analysis of false-negative cases.

Authors:  Mary F Dillon; Arnold D K Hill; Cecily M Quinn; Ann O'Doherty; Enda W McDermott; Niall O'Higgins
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

8.  A comparison of diagnostic performance of vacuum-assisted biopsy and core needle biopsy for breast microcalcification: a systematic review and meta-analysis.

Authors:  Xu Chen Huang; Xu Hua Hu; Xiao Ran Wang; Chao Xi Zhou; Fei Fei Wang; Shan Yang; Gui Ying Wang
Journal:  Ir J Med Sci       Date:  2018-03-16       Impact factor: 1.568

Review 9.  When can stereotactic core biopsy replace excisional biopsy?--A clinical perspective.

Authors:  M Morrow
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

10.  Agreement between preoperative core needle biopsy and postoperative invasive breast cancer histopathology is not dependent on the amount of clinical material obtained.

Authors:  R O'Leary; K Hawkins; J C S Beazley; M R J Lansdown; A M Hanby
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.